What should I know about Hepatitis B vaccine?
Most infants receive a vaccine against hepatitis B soon after birth - almost always before leaving the hospital. Then two more doses are served between one to two months and six to eighteen months. It is recommended that infants whose mothers are positively tested for hepatitis B or whose condition is not known to receive the final dose of this vaccine by six months of age.
Hepatitis B is a liver disease. It is able to cause either a mild disease or a more serious, long -term disease that can lead to liver or cancer disease. The National Vaccine Information Center states that “90-95% of all hepatitis B cases B is often transmitted by sexual contact with an infected partner after three to four weeks of nausea. Contact in the medical environment.Infected mothers on their child during birth.
Because children who were not born of mothers who have hepatitis B are not at high risk of infecting the disease, why vaccinate all newborns? Hepatitis B vaccine has been available since 1981, but has only been added to the routine vaccination plan ten years later. At the beginning, the vaccine focused on adults in groups with a high risk of closing the disease; However, it was difficult because many of these adults denied that they had any risk factors. Therefore, it was considered to be more effective to simply administer the vaccine at birth, with the intention of immunizing individuals through adulthood.
Although the study has reported the greatest occurrence of hepatitis B, which occurs in adults aged 20 to 39 years, we do not have a way to know whether ITIS B hepatvaccine will still be effective many years later.
though only17% of doctors give problems such as fever, fatigue, headache and joint pain after receiving this vaccine, more than 16,000 reports on adverse side effects after vaccination have been reported in the system of adverse vaccines. After vaccination against hepatitis B, the deaths of newborns were reported, but are almost always classified as a sudden infant syndrome (SIDS), although SIDS is not generally recognized in medical literature as in infants within two months of age.
Given the potential side effects and the fact that infants of healthy mothers are not exposed to high risk of infecting hepatitis B, many parents question the wisdom of this particular vaccine. Although there is a vaccine against hepatitis B, which does not contain Thimerosal, a common and worrying component of the vaccine, security studies included only a few thousand APOs of vaccination watched them less than one week. No evidence was provided that the immune and/or neurological system is not endangered by the receipt of this bagtin in the coming weeks, months or years.
As with any vaccine, the risk of side effects may be reduced by deciding to serve separately from any other vaccine. The expectant mothers who decide to log out of the Hepatitis B vaccine for their newborns should choose from medical staff before delivery; Otherwise, it is probably assumed that the shot should be served as usual.